Dr Reddy’s gets 30 days to sell ‘Olymviq’ stock in Novo trademark case
Dr Reddy’s has agreed to rebrand semaglutide drug amid a dispute with Novo Nordisk.
Dr Reddy’s has agreed to rebrand semaglutide drug amid a dispute with Novo Nordisk.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
